NORFOLK, Va., Jan. 14, 2020 /PRNewswire/ —Embody, Inc., a privately-held medical device company focused on soft tissue repair, announced today they have received a notice of award on a $2.5 million Phase II SBIR through the Defense Advanced Research Projects Agency (DARPA), extending the total funding from DARPA to $14.35 million in non-dilutive funding.  The Phase II award will fund the …